Yasuto Naoi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Positive Breast Cancer

Endoplasmic Reticulum

Gas Chromatography

Top Venues

Breast cancer (Tokyo, Japan)

Breast cancer research and treatment

This page only lists publications with an associated author ORCID identifier.

Publications

Sae Kitano, Ryo Tsunashima, Chikage Kato, Akira Watanabe, Yoshiaki Sota, Saya Matsumoto, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer. Breast cancer (Tokyo, Japan) (2024)
Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan) (2024)
Sae Kitano, Ryo Tsunashima, Chikage Kato, Akira Watanabe, Yoshiaki Sota, Saya Matsumoto, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Validation of late recurrence prediction by gene expression profiles and clinicopathological factors in estrogen receptor-positive breast cancer. Breast cancer (Tokyo, Japan) 31 (5) (2024)
Akira Watanabe, Ryo Tsunashima, Chikage Kato, Sae Kitano, Saya Matsumoto, Yoshiaki Sota, Midori Morita, Koichi Sakaguchi, Yasuto Naoi
Investigation of recurrence prediction ability of EndoPredict ® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict ® from microarray data from fresh-frozen to FFPE tissues. Breast cancer (Tokyo, Japan) 31 (4) (2024)
Ako Ohara, Yasuto Naoi, Masafumi Shimoda, Tomonori Tanei, Naofumi Kagara, Tomohiro Miyake, Yoshiaki Sota, Seung Jin Kim, Kenzo Shimazu, Shinzaburo Noguchi
Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer. Breast cancer (Tokyo, Japan) 28 (4) (2021)
Yasuto Naoi, Ryo Tsunashima, Kenzo Shimazu, Shinzaburo Noguchi
The multigene classifiers 95GC/42GC/155GC for precision medicine in ER-positive HER2-negative early breast cancer. Cancer science 112 (4) (2021)
Seiichi Imanishi, Yasuto Naoi, Kenzo Shimazu, Masafumi Shimoda, Naofumi Kagara, Tomonori Tanei, Tomohiro Miyake, Seung Jin Kim, Shinzaburo Noguchi
Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC. Breast cancer research and treatment 174 (3) (2019)
Ako Matsushita Ohara, Yasuto Naoi, Kenzo Shimazu, Naofumi Kagara, Masafumi Shimoda, Tomonori Tanei, Tomohiro Miyake, Seung Jin Kim, Shinzaburo Noguchi
PAM50 for prediction of response to neoadjuvant chemotherapy for ER-positive breast cancer. Breast cancer research and treatment 173 (3) (2018)
Ryo Tsunashima, Yasuto Naoi, Kenzo Shimazu, Naofumi Kagara, Masashi Shimoda, Tomonori Tanei, Tomohiro Miyake, Seung Jin Kim, Shinzaburo Noguchi
Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients. Breast cancer research and treatment 171 (1) (2018)